689 related articles for article (PubMed ID: 28366226)
1. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
2. Specific deletion connexin43 in astrocyte ameliorates cognitive dysfunction in APP/PS1 mice.
Ren R; Zhang L; Wang M
Life Sci; 2018 Sep; 208():175-191. PubMed ID: 30031059
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model.
Reichenbach N; Delekate A; Plescher M; Schmitt F; Krauss S; Blank N; Halle A; Petzold GC
EMBO Mol Med; 2019 Feb; 11(2):. PubMed ID: 30617153
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
[TBL] [Abstract][Full Text] [Related]
5. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
6. Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer's mice.
Sawmiller D; Koyama N; Fujiwara M; Segawa T; Maeda M; Mori T
J Biol Chem; 2023 Jul; 299(7):104846. PubMed ID: 37211092
[TBL] [Abstract][Full Text] [Related]
7. Ca
Yu Z; Dou F; Wang Y; Hou L; Chen H
J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
[TBL] [Abstract][Full Text] [Related]
8. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
[TBL] [Abstract][Full Text] [Related]
10. Daphnetin ameliorates Aβ pathogenesis via STAT3/GFAP signaling in an APP/PS1 double-transgenic mouse model of Alzheimer's disease.
Gao P; Wang Z; Lei M; Che J; Zhang S; Zhang T; Hu Y; Shi L; Cui L; Liu J; Noda M; Peng Y; Long J
Pharmacol Res; 2022 Jun; 180():106227. PubMed ID: 35452800
[TBL] [Abstract][Full Text] [Related]
11. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer's disease.
Tao CC; Cheng KM; Ma YL; Hsu WL; Chen YC; Fuh JL; Lee WJ; Chao CC; Lee EHY
Cell Death Differ; 2020 Jan; 27(1):192-209. PubMed ID: 31127200
[TBL] [Abstract][Full Text] [Related]
13. Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice.
Shi XM; Zhang H; Zhou ZJ; Ruan YY; Pang J; Zhang L; Zhai W; Hu YL
Biomed Pharmacother; 2018 Feb; 98():553-565. PubMed ID: 29288971
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
[TBL] [Abstract][Full Text] [Related]
15. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
16. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells.
Chen Y; Zhou C; Abdelhamid M; Jung CG; Michikawa M
J Biochem; 2023 Oct; 174(5):409-420. PubMed ID: 37488092
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
[TBL] [Abstract][Full Text] [Related]
19. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
Corona AW; Kodoma N; Casali BT; Landreth GE
J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
[TBL] [Abstract][Full Text] [Related]
20. (E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates LPS-Mediated Memory Impairment by Inhibition of STAT3 Pathway.
Choi JY; Hwang CJ; Lee DY; Gu SM; Lee HP; Choi DY; Oh KW; Han SB; Hong JT
Neuromolecular Med; 2017 Dec; 19(4):555-570. PubMed ID: 29052076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
